Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: RxSight Inc., 3 years.
RxSight Inc.
Director
CeriBell Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | RxSight Inc. | Grant or award | +37,037 | — | — |
| Jun 2, 2026 | CeriBell Inc. | Grant or award | +7,838 | — | — |
| Jun 10, 2025 | CeriBell Inc. | Grant or award | +8,828 | — | — |
| Jun 3, 2025 | RxSight Inc. | Grant or award | +10,752 | — | — |
| Oct 15, 2024 | CeriBell Inc. | Derivative conversion | +2,140,600 | — | — |
| Oct 15, 2024 | CeriBell Inc. | Open-market purchase | +237,234 | $17.00 | $4,032,978 |
| Oct 11, 2024 | CeriBell Inc. | Grant or award | +6,618 | — | — |
| Jun 6, 2024 | RxSight Inc. | Grant or award | +2,554 | — | — |
| May 17, 2024 | RxSight Inc. | Open-market purchase | +5,000 | $61.09 | $305,450 |
| Feb 14, 2024 | RxSight Inc. | Open-market purchase | +4,000 | $51.29 | $205,160 |
| Feb 12, 2024 | RxSight Inc. | Open-market purchase | +4,000 | $50.38 | $201,520 |
| Nov 30, 2023 | RxSight Inc. | Other | −445,400 | — | — |
| Nov 30, 2023 | RxSight Inc. | Other | +693 | — | — |
| Nov 30, 2023 | RxSight Inc. | Other | +1,617 | — | — |
| Nov 29, 2023 | RxSight Inc. | Open-market sale | −349,245 | $29.77 | $10,397,024 |
Questions about Bakker Juliet Tammenoms
What boards is Bakker Juliet Tammenoms on?
Bakker Juliet Tammenoms sits on the boards of CeriBell Inc. and RxSight Inc.
How long has Bakker Juliet Tammenoms served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.